Palonosetron Kalceks

Palonosetron, the active ingredient in Palonosetron Kalceks, is a selective 5‑HT3 receptor antagonist presented as a sterile injectable solution for intravenous use. It is used to prevent chemotherapy‑induced nausea and vomiting in adult cancer patients. GNH USA supplies Palonosetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Palonosetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Palonosetron is indicated for prevention of nausea and vomiting associated with chemotherapy and postoperative settings. - Chemotherapy‑induced nausea and vomiting (CINV): Reduces the incidence of acute and delayed nausea and vomiting following highly emetogenic chemotherapy. - Moderately emetogenic chemotherapy (MEC): Provides effective prophylaxis against nausea and vomiting in patients receiving moderate‑risk regimens. - Post‑operative nausea and vomiting (PONV): Decreases the frequency of the post‑surgical vomiting and nause after general anesthesia. - Ant ​  

Palitos